» Articles » PMID: 34124193

Aortic Valve Sclerosis As an Important Predictor of Long-Term Mortality in Patients With Carotid Atheromatous Plaque Requiring Carotid Endarterectomy

Abstract

A strong association between aortic valve sclerosis (AVSc), the earliest manifestation of calcific aortic valve disease, and atherosclerosis exists. The aim of the study was to evaluate the predictive capabilities of AVSc on long-term all-cause mortality, in patients requiring carotid endarterectomy (CEA). 806 consecutive CEA patients were enrolled. Preoperative echocardiography was used to assess AVSc. Computed tomography angiography was applied for plaque characterization. Kaplan-Meier curves, Cox linear regression, and area under the receiving operator characteristic (AUC) curve analyses were used to evaluate the predictive capability of AVSc. Overall, 348 of 541 patients had AVSc (64%). Age, diabetes, and estimated glomerular filtration rate (eGFR) were associated with AVSc. In the 5-year follow-up, AVSc group had a mortality rate of 16.7% while in no-AVSc group was 7.8%. Independent predictors of all-cause mortality were age, sex, eGFR, left ventricular ejection fraction, and AVSc. After adjustments, AVSc was associated with a significant increase in all-cause mortality risk (hazard ratio, HR = 1.9; 95%CI: 1.04-3.54; = 0.038). We stratify our cohort based on carotid atheromatous plaque-type: soft, calcified, and mixed-fibrotic. In patients with mixed-fibrotic plaques, the mortality rate of AVSc patients was 15.5% compared to 2.4% in no-AVSc patients. In this group, AVSc was associated with an increased long-term all-cause mortality risk with an adjusted HR of 12.8 (95%CI: 1.71-96.35; = 0.013), and the AUC, combing eGFR and AVSc was 0.77 ( < 0.001). Our findings indicate that AVSc together with eGFR may be used to improve long-term risk stratification of patients undergoing CEA surgery.

Citing Articles

Whole-Blood Transcriptome Unveils Altered Immune Response in Acute Myocardial Infarction Patients With Aortic Valve Sclerosis.

Piacentini L, Myasoedova V, Chiesa M, Vavassori C, Moschetta D, Valerio V Arterioscler Thromb Vasc Biol. 2023; 44(2):452-464.

PMID: 38126173 PMC: 10805353. DOI: 10.1161/ATVBAHA.123.320106.


Purinergic Receptor P2Y2 Stimulation Averts Aortic Valve Interstitial Cell Calcification and Myofibroblastic Activation.

Moschetta D, Di Maria E, Valerio V, Massaiu I, Bozzi M, Songia P Biomedicines. 2022; 10(2).

PMID: 35203666 PMC: 8962345. DOI: 10.3390/biomedicines10020457.

References
1.
Lutgens E, Gijbels M, Smook M, Heeringa P, Gotwals P, Koteliansky V . Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol. 2002; 22(6):975-82. DOI: 10.1161/01.atv.0000019729.39500.2f. View

2.
Alves-Ferreira J, Rocha-Neves J, Dias-Neto M, Braga S . Poor long-term outcomes after carotid endarterectomy: a retrospective analysis of two portuguese centers. Scand Cardiovasc J. 2019; 53(5):266-273. DOI: 10.1080/14017431.2019.1638518. View

3.
Katano H, Mase M, Nishikawa Y, Yamada H, Yamada K . Analysis of Recurrent Stenosis After Carotid Endarterectomy Featuring Primary Plaque Calcification. Neurosurgery. 2017; 80(6):863-870. DOI: 10.1093/neuros/nyw119. View

4.
Takaya N, Yuan C, Chu B, Saam T, Underhill H, Cai J . Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI--initial results. Stroke. 2006; 37(3):818-23. DOI: 10.1161/01.STR.0000204638.91099.91. View

5.
Gharacholou S, Karon B, Shub C, Pellikka P . Aortic valve sclerosis and clinical outcomes: moving toward a definition. Am J Med. 2011; 124(2):103-10. DOI: 10.1016/j.amjmed.2010.10.012. View